Related Articles
Systemic chemotherapy with FOLFOX in metastatic grade 1/2 neuroendocrine cancer
Outcomes of stage II‑IV upper‑tract urothelial carcinoma and adjuvant chemotherapy for locally advanced cancer
Metastatic renal cancer and patient survival as a criterion of treatment response
Prognostic value of PAX9 in patients with esophageal squamous cell carcinoma and its prediction value to radiation sensitivity
Apatinib combined with chemotherapy in patients with previously treated advanced breast cancer: An observational study